NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a clinical-stage global biopharmaceutical company focused on using its novel technology ...
FLORHAM PARK, N.J., March 25, 2026 (GLOBE NEWSWIRE)-- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results